Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT001 vs Sufentanil vs Ketamine for Acute Dental Pain
NCT05508594Phase 3Completed
- Sponsor
- Cessatech
- Start
- Sep 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of sufentanil, ketamine in acute pain, sponsored by Cessatech. Started Sep 2022; status: completed.
02
Drugs
sufentanilketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05508594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05508594.